153 related articles for article (PubMed ID: 10084277)
1. The effect of latanoprost and brimonidine on rabbit subconjunctival fibroblasts.
Lark KK; Pasha AS; Yan X; Edward DP
J Glaucoma; 1999 Feb; 8(1):72-6. PubMed ID: 10084277
[TBL] [Abstract][Full Text] [Related]
2. Comparison between latanoprost and brimonidine efficacy and safety in Indian eyes.
Thomas R; Parikh R; Muliyil J; George R; Paul P; Abraham LM
Indian J Ophthalmol; 2003 Jun; 51(2):123-8. PubMed ID: 12831141
[TBL] [Abstract][Full Text] [Related]
3. Effect of latanoprost and timolol on the histopathology of the rabbit conjunctiva.
Mietz H; Schlötzer-Schrehardt U; Strassfeld C; Krieglstein GK
Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):679-87. PubMed ID: 11222527
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the early effects of brimonidine and apraclonidine as topical ocular hypotensive agents.
Maus TL; Nau C; Brubaker RF
Arch Ophthalmol; 1999 May; 117(5):586-91. PubMed ID: 10326954
[TBL] [Abstract][Full Text] [Related]
5. Reaction of Müller cells in an experimental rat model of increased intraocular pressure following timolol, latanoprost and brimonidine.
Vidal L; Díaz F; Villena A; Moreno M; Campos JG; Pérez de Vargas I
Brain Res Bull; 2010 Apr; 82(1-2):18-24. PubMed ID: 20206241
[TBL] [Abstract][Full Text] [Related]
6. Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments.
Hernández M; Urcola JH; Vecino E
Exp Eye Res; 2008 May; 86(5):798-806. PubMed ID: 18394603
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of brimonidine, dorzolamide and latanoprost as adjunctive therapy in primary open angle glaucoma.
Sodhi PK; Pandey RM; Ratan SK
Int J Clin Pract; 2003 Dec; 57(10):875-8. PubMed ID: 14712889
[TBL] [Abstract][Full Text] [Related]
8. Effect of treatment by medicine or surgery on intraocular pressure and pulsatile ocular blood flow in normal-pressure glaucoma.
Poinoosawmy D; Indar A; Bunce C; Garway-Heath DF; Hitchings RA
Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):721-6. PubMed ID: 12271368
[TBL] [Abstract][Full Text] [Related]
9. Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma.
Quaranta L; Gandolfo F; Turano R; Rovida F; Pizzolante T; Musig A; Gandolfo E
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2917-23. PubMed ID: 16799034
[TBL] [Abstract][Full Text] [Related]
10. Assessment of ocular hypotensive mechanisms and additivity of antiglaucoma drugs in humans.
Kaufman PF
Arch Ophthalmol; 1999 May; 117(5):673-4. PubMed ID: 10326968
[No Abstract] [Full Text] [Related]
11. Effect of 15-keto latanoprost on intraocular pressure and aqueous humor dynamics in monkey eyes.
Wang RF; Gagliuso DJ; Mittag TW; Podos SM
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4143-7. PubMed ID: 17724199
[TBL] [Abstract][Full Text] [Related]
12. Comparing brimonidine 0.2% to apraclonidine 1.0% in the prevention of intraocular pressure elevation and their pupillary effects following laser peripheral iridotomy.
Yuen NS; Cheung P; Hui SP
Jpn J Ophthalmol; 2005; 49(2):89-92. PubMed ID: 15838723
[TBL] [Abstract][Full Text] [Related]
13. Effect of topical brinzolamide 1% and brimonidine 0.2% on intraocular pressure after phacoemulsification.
Cetinkaya A; Akman A; Akova YA
J Cataract Refract Surg; 2004 Aug; 30(8):1736-41. PubMed ID: 15313300
[TBL] [Abstract][Full Text] [Related]
14. Effect of topical ophthalmic latanoprost on intraocular pressure in normal horses.
Davidson HJ; Pinard CL; Keil SM; Brightman AH; Sargeant JM
Vet Ther; 2002; 3(1):72-80. PubMed ID: 12050830
[TBL] [Abstract][Full Text] [Related]
15. Safety assessment of subconjunctivally implanted devices containing latanoprost in Dutch-belted rabbits.
Jessen BA; Shiue MH; Kaur H; Miller P; Leedle R; Guo H; Evans M
J Ocul Pharmacol Ther; 2013; 29(6):574-85. PubMed ID: 23489175
[TBL] [Abstract][Full Text] [Related]
16. Injection of cultured autologous fibroblasts into the subconjunctival space of rabbits treated with mitomycin C.
Hwang JM; Kee C
Am J Ophthalmol; 2006 Aug; 142(2):259-63. PubMed ID: 16876506
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
Stewart WC; Konstas AG; Nelson LA; Kruft B
Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of latanoprost when stored at room temperature.
Mochizuki H; Itakura H; Takamatsu M; Kiuchi Y
Hiroshima J Med Sci; 2008 Jun; 57(2):69-72. PubMed ID: 18717189
[TBL] [Abstract][Full Text] [Related]
19. Comparison of additional intraocular pressure-lowering effects of latanoprost vs brimonidine in primary open-angle glaucoma patients with intraocular pressure uncontrolled by timolol-dorzolamide combination.
Akman A; Cetinkaya A; Akova YA; Ertan A
Eye (Lond); 2005 Feb; 19(2):145-51. PubMed ID: 15184958
[TBL] [Abstract][Full Text] [Related]
20. Effects of antiglaucoma drops on MMP and TIMP balance in conjunctival and subconjunctival tissue.
Ito T; Ohguro H; Mamiya K; Ohguro I; Nakazawa M
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):823-30. PubMed ID: 16505013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
